These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26952004)

  • 1. The analysis of dose-response curve from bioassays with quantal response: Deterministic or statistical approaches?
    Mougabure-Cueto G; Sfara V
    Toxicol Lett; 2016 Apr; 248():46-51. PubMed ID: 26952004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mass-action law based algorithms for quantitative econo-green bio-research.
    Chou TC
    Integr Biol (Camb); 2011 May; 3(5):548-59. PubMed ID: 21403972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution of the maximum likelihood estimator in up-and-down experiments for quantal dose-response data.
    Vågerö M; Sundberg R
    J Biopharm Stat; 1999 Aug; 9(3):499-519. PubMed ID: 10473034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioning on certain random events associated with statistical variability in PK/PD.
    Beal SL
    J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):213-43. PubMed ID: 16283533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Model and inference for quantal response pharmacological assay].
    Kawai N; Goto M
    Nihon Yakurigaku Zasshi; 2000 Jul; 116(1):29-35. PubMed ID: 10976450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of the biometrician in dosage finding].
    Schneider B
    Arzneimittelforschung; 1977 Feb; 27(2A):257-64. PubMed ID: 577172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient design for estimation of median lethal dose and quantal dose-response curves.
    Kalish LA
    Biometrics; 1990 Sep; 46(3):737-48. PubMed ID: 2242412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response studies: how do we make them conclusive?
    Källén A; Larsson P
    Stat Med; 1999 Mar; 18(6):629-41. PubMed ID: 10204194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of optimal dose.
    Khan MK; Khan MA
    Comput Biomed Res; 1985 Apr; 18(2):193-203. PubMed ID: 3987233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of ADMET Properties.
    Norinder U; Bergström CA
    ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kernel estimates of dose response.
    Staniswalis JG; Cooper V
    Biometrics; 1988 Dec; 44(4):1103-19. PubMed ID: 3233249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A note on multiple testing procedures in dose finding.
    Bauer P
    Biometrics; 1997 Sep; 53(3):1125-8. PubMed ID: 9333343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two approaches to the construction of models for quantal responses to mixtures of drugs.
    Plackett RL; Hewlett PS
    Biometrics; 1967 Mar; 23(1):27-44. PubMed ID: 6050470
    [No Abstract]   [Full Text] [Related]  

  • 14. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.
    Goldoni M; Johansson C
    Toxicol In Vitro; 2007 Aug; 21(5):759-69. PubMed ID: 17420112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of methods of benchmark-dose estimation for continuous response data.
    West RW; Kodell RL
    Risk Anal; 1999 Jun; 19(3):453-9. PubMed ID: 10765417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of some methods for fitting dose-response models to quantal-response developmental toxicology data.
    Carr GJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):779-91. PubMed ID: 8241373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robustness of choice of number of doses for maximum likelihood estimation of the ED(50) in bioassay.
    Huang Y
    Stat Med; 2002 Aug; 21(15):2215-23. PubMed ID: 12210634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general noninteractive multiple toxicity model including probit, logit, and Weibull transformations.
    Christensen ER; Chen CY
    Biometrics; 1985 Sep; 41(3):711-25. PubMed ID: 4074820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.